Yaushe GlaxoSmithkline Pharmaceuticals Limited ya wallafa wata sanarwa da asara?Rahotanni na GlaxoSmithkline Pharmaceuticals Limited da kuma asarar da aka wallafa sau ɗaya a cikin kwata, an wallafa asusun ajiyar kuɗi na GlaxoSmithkline Pharmaceuticals Limited a ranar 30/09/2018. Mene ne riba daga hannun jari na GlaxoSmithkline Pharmaceuticals Limited?Abinda aka kiyasta ta hannun GlaxoSmithkline Pharmaceuticals Limited ya kasance 6.65 Rs a cikin rahoton kudi na ƙarshe. Yaushe GlaxoSmithkline Pharmaceuticals Limited zai buga bayanan asara da asarar gaba?Rahoton na gaba akan asusun riba da asarar GlaxoSmithkline Pharmaceuticals Limited zai kasance ranar Disamba 2024. GlaxoSmithkline Pharmaceuticals Limited albashi a rabon - halayen kuɗi na kamfanin akan girman darajar sa. Ana tara albashin da kashi ɗaya cikin sauki - duk ribar kamfanin don rahoton hada-hadar kuɗi ya raba ta hannun adadin hannun jari. A bayyane yake cewa GlaxoSmithkline Pharmaceuticals Limited Albashin kowace riba halayen kuɗi ne na wani lokaci. Riba na GlaxoSmithkline Pharmaceuticals Limited - jimlar riba na lokacin hada-hadar kudi. |
|||||||||||||||||
|
|||||||||||||||||
Riba GlaxoSmithkline Pharmaceuticals LimitedGlaxoSmithkline Pharmaceuticals Limited riba mai tsoka ne don tunani kawai kuma ba shi da ban sha'awa ga masu hannun jeri. Mafi nuna alama mai ban sha'awa ita ce riba ta kowace kashi, wanda kai tsaye ke rinjayar adadin rabon kowane rabo. An kafa ranar GlaxoSmithkline Pharmaceuticals Limited rahoton ribar ne ta hanyar gudanarwar kungiyar. Kowace ranar GlaxoSmithkline Pharmaceuticals Limited Bayanin riba ya dace da layi a cikin teburin sabis. |
|||||||||||||||||
|
|
|||||||||||||||||
Bincike na hamsin GlaxoSmithkline Pharmaceuticals LimitedAbubuwan da suka samu ta hanyar GlaxoSmithkline Pharmaceuticals Limited an kirga su daidai da tsarin da aka samu: kudin shiga da ya raba hannun jarin duk hannun jari a kamfanin. Ana samun albashi ta kashin GlaxoSmithkline Pharmaceuticals Limited ana la'akari da shi na wani lokacin kudi sannan kuma ana bayar da rahoton rahoton kuɗi akan ribar kamfanin gaba ɗaya. GlaxoSmithkline Pharmaceuticals Limited ana samun albashi ta kowane rashi don lokacin rahoton da ya gabata a teburinmu (saman layi) ko jadawali (shafi mafi kyau). Profitwararrun riba GlaxoSmithkline Pharmaceuticals Limited shine mafi yawan nau'ikan rahoton rahoton kuɗi don ƙididdigar kuɗi. |
|||||||||||||||||
GlaxoSmithkline Pharmaceuticals Limited Albashin da ya samu na kwata-kwata da kashi ɗaya shine ƙimar ribar kamfanin. Suna da mahimmanci matsakaici a tsakanin manazarta. Amma samun kuɗi na shekara-shekara ta rabon suna da mahimmanci. Profitarshen kwata-kwata GlaxoSmithkline Pharmaceuticals Limited yanzu ana ɗaukar shi a matsayin ribar kwata-kwata ƙarshen ƙulli na ƙarshen wannan shekarar. Canji cikin riba GlaxoSmithkline Pharmaceuticals Limited na shekara ƙimar ƙididdigar ne don ƙarin bayani wanda ke nuna canji cikin ribar riba tare da tazara ta bara. Canje-canje a cikin GlaxoSmithkline Pharmaceuticals Limited ribar kwata idan aka kwatanta da bara na iya zama mai mahimmanci ga kamfanoni masu kasuwancin lokaci. Amma babban mai nuna alamun riba na kamfanin shine canjin shekara na riba. An nuna alamun ƙarfafa ribar kamfanin a matsayin kashi. A cikin teburin sabis ɗin Ribar da ke kan wannan shafin, zaku iya samun tarihin GlaxoSmithkline Pharmaceuticals Limited riba na lokutan rahoton da suka gabata, don bara ko wani tazara. GlaxoSmithkline Pharmaceuticals Limited Tarihin samun kuɗaɗen shiga ana samun su akan layi sama da shekaru 10 da suka gabata. The GlaxoSmithkline Pharmaceuticals Limited cibiyar tattara ribar kamfanin na shekarun da suka gabata ana samun su daga hanyoyin buɗe. |
|||||||||||||||||
Kudin hannun jari GlaxoSmithkline Pharmaceuticals Limited |
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Finance GlaxoSmithkline Pharmaceuticals Limited |
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
|
|